cosmetic · Compound Profile

Melanotan I

Melanotan 1 · MT-1 · Afamelanotide · Scenesse

A synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH) that selectively activates the MC1 receptor to increase eumelanin production, FDA-approved as Scenesse for erythropoietic protoporphyria.

skin
Reviewed against editorial standards
Partner

Research Peptides

BioLongevity Labs15% Off
Shop Peptides at BioLongevity Labs

Advertiser link — we may earn a commission at no extra cost to you.

What is Melanotan I?

Content coming soon. This guide will cover the mechanism of action, research background, and current status of Melanotan I.

Potential Benefits

Content coming soon. Research-backed potential benefits of Melanotan I.

Dosage & Administration

Content coming soon. Common research dosage protocols for Melanotan I.

Side Effects & Safety

Content coming soon. Known side effects and safety considerations.

How to Reconstitute Melanotan I

Content coming soon. Step-by-step reconstitution guide.

Compare

Related comparisons

Melanotan I vs Melanotan IIskin

Similar Compounds

Related peptides

Compounds with a similar mechanism or used for related goals.

Melanotan IIA synthetic melanocortin receptor agonist researched for its effects on skin pigmentation and photoprotection.GHK-CuA naturally occurring copper-binding tripeptide with research interest in skin remodeling, wound healing, and hair growth.GLOWA cosmetic peptide blend designed to support skin radiance, elasticity, and collagen production through synergistic peptide signaling.OS-01A proprietary peptide developed by OneSkin targeting senescent cells in skin, marketed as the first topical senolytic for skin longevity and age reversal.PT-141An FDA-approved melanocortin receptor agonist originally derived from melanotan II, used for hypoactive sexual desire disorder.

Researching peptides? We did the hard part.

Get our free Peptide Starter Kit — the 5 most researched compounds, simplified into one actionable guide.

No spam · Unsubscribe anytime

Related Reading

AD
Austin Danner

Founder & Editor in Chief

Founder of Peptides Insider. Independent researcher focused on translating peer-reviewed peptide research into practical, evidence-based guides.

Reviewed against Peptides Insider editorial standards.